MET in gastric cancer – discarding a 10% cutoff rule

AIMS: We aimed to develop a putative predictive biomarker score for future hepatocyte growth factor receptor (MET)‐targeted therapy of gastric cancer (GC). METHODS AND RESULTS: MET expression and MET amplification were analysed by immunohistochemistry (IHC) and chromogenic in‐situ hybridization (CIS...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Histopathology
Main Authors: Metzger, Marie‐Luise, Behrens, Hans‐Michael, Böger, Christine, Haag, Jochen, Krüger, Sandra, Röcken, Christoph
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2015
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4744765/
https://ncbi.nlm.nih.gov/pubmed/26033401
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/his.12745
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados